Recent News for STOK - Stoke Therapeutics, Inc.

Date Title
Dec 8 Stoke Therapeutics Presents Preclinical Data on the Biodistribution, Target Engagement and Safety of STK-001 in Non-Human Primates That Support the Planned Clinical Development of STK-001 for the Treatment of Dravet Syndrome
Dec 7 Stoke Therapeutics Presents Preclinical Data From Studies of STK-001 That Showed Improvements in Survival and Reductions in Seizure Frequency in a Mouse Model of Dravet Syndrome
Dec 6 Hedge Funds Love Liberty Tripadvisor (LTRPA) Way More Than These 3 Stocks
Nov 26 Stoke Therapeutics to Present at Piper Jaffray 31st Annual Healthcare Conference
Nov 25 Stoke Therapeutics to Present New Preclinical Data on STK-001 at the American Epilepsy Society Annual Meeting
Nov 22 Can The Uptrend Continue for Stoke Therapeutics?
Nov 12 SunTrust sees 16% upside in Amgen in premarket analyst action
Nov 12 Stoke Therapeutics EPS beats by $0.02
Nov 12 Stoke Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
Nov 5 Stoke Therapeutics to Present at Upcoming Investor Conferences in November
Oct 28 Hedge Funds Have Never Been This Bullish On Stoke Therapeutics, Inc. (STOK)
Oct 16 Stoke Therapeutics Strengthens Leadership Team With Appointments of Robin A. Walker, J.D., as Senior Vice President, Chief Legal Officer and Joan Wood as Head of Human Resources
Sep 30 Stoke Therapeutics to Present at 2019 Cantor Global Healthcare Conference
Sep 20 We're Not Very Worried About Stoke Therapeutics's (NASDAQ:STOK) Cash Burn Rate
Sep 20 The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering
Sep 16 ALDR, OSTK, PBF, SEMG and STOK among midday movers
Sep 11 Stoke Therapeutics added to Russell 2000 and 3000 indexes
Sep 11 Stoke Therapeutics Added to Russell 2000 and 3000 Indexes
Sep 10 MMSI, OLED, STOK and WEN among midday movers
Sep 10 Mallinckrodt leads healthcare gainers; Cesca Therapeutics among losers
Aug 30 The Daily Biotech Pulse: Genmab-Novartis Multiple Sclerosis Drug Aces Late-Stage Studies, Akari Nets Orphan Drug Designation
Aug 30 3 New Biotech Stocks That Keep On Soaring
Aug 27 Stocks That Hit 52-Week Highs On Tuesday
Aug 21 The Daily Biotech Pulse: Ra Medical Earns Milestone, Aimmune Doses Patient In Egg Allergy Trial, Cara In-Licenses Platform
Aug 21 The Daily Biotech Pulse: Ra Pharma Earns Milestone, Aimmune Doses Patient In Egg Allergy Trial, Cara In-Licenses Platform

Back to the Main STOK Page...